20 results
DEF 14A
PROK
ProKidney Corp - Ordinary Shares
26 May 23
Definitive proxy
8:00am
)
Board Size
Total Number of Directors
Gender Identity
Female
Male
Non-Binary
Did Not
Disclose Gender
Directors
Demographic Background
African American … , perspectives, experience, age, gender, ethnicity and country of citizenship on the Board and its committees.
If a shareholder wishes to propose
8-K
EX-99.1
PROK
ProKidney Corp - Ordinary Shares
14 Nov 22
ProKidney Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
10:34am
prevalence, gender differences in disease progression and prescriber trends of newly introduced CKD medications by the professional community.
Successfully
8-K
EX-3.1
mch6u
15 Jul 22
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq
5:24pm
DEFA14A
w3hfgfn3mgk4ioax8bsv
11 May 22
Additional proxy soliciting materials
4:55pm
DEFA14A
huf5ibwd
21 Jan 22
Additional proxy soliciting materials
4:38pm
8-K/A
EX-2.1
pbr5lr4
21 Jan 22
Entry into a Material Definitive Agreement
4:33pm
DEFA14A
fxy50
18 Jan 22
Additional proxy soliciting materials
5:15pm
DEFA14A
09elvwhdg 4rbimi
18 Jan 22
Additional proxy soliciting materials
7:14am
8-K
EX-99.2
esws655r2 j51
18 Jan 22
Entry into a Material Definitive Agreement
7:05am
8-K
EX-3.1
b1pk6
2 Jul 21
Social Capital Suvretta Holdings Corp. III Announces Pricing of Upsized $220,000,000 Initial Public Offering
4:22pm
S-1
EX-3.1
pr00ms1q7 11
2 Jun 21
IPO registration
5:17pm
S-1
EX-10.5
17weu9nw26k6o2r0 p5l
2 Jun 21
IPO registration
5:17pm
S-1
EX-3.2
gip3hqkp
2 Jun 21
IPO registration
5:17pm
- Prev
- 1
- Next